HOUSE FILE 225

BY  HEATON

A BILL FOR

An Act relating to the disclosure of relationships with pharmaceutical manufacturers by members of the medical assistance pharmaceutical and therapeutics committee and the drug utilization review commission. 
BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA:

   Section 1.  Section 249A.20A, subsection 2, Code 2011, is amended by adding the following new paragraph: 
   NEW PARAGRAPH.  d.  A member of the committee shall disclose to the department, in a format and in accordance with a schedule prescribed by rule of the department, any financial relationship or affiliation with a pharmaceutical manufacturer including but not limited to any payments or contributions for lectures, consulting, research, or other services.
   Sec. 2.  Section 249A.24, Code 2011, is amended by adding the following new subsection:
   NEW SUBSECTION.  4.  A member of the commission shall disclose to the department, in a format and in accordance with a schedule prescribed by rule of the department, any financial relationship or affiliation with a pharmaceutical manufacturer including but not limited to any payments or contributions for lectures, consulting, research, or other services. 
EXPLANATION
   This bill requires a member of the medical assistance pharmaceutical and therapeutics committee or a member of the medical assistance drug utilization review commission to disclose to the department of human services any financial relationship or affiliation with a pharmaceutical manufacturer including but not limited to any payments or contributions for lectures, consulting, research, or other services. The members are to disclose the information in a format and in accordance with a schedule prescribed by rule of the department of human services.